Nirsevimab excels in preventing infant hospitalization for RSV
Compared with maternal vaccination with the RSVpreF (respiratory syncytial virus prefusion F) protein vaccine, infant immunization with nirsevimab is associated with a lower risk of RSV-related hospitalization, researchers… read more.




